Pharmacokinetics of once-daily IP gentamicin in CAPD patients

Peritoneal Dialysis International

Volumn 16, Issue 4, 1996, Pages 379-384

  Low, Chai Luan ^a   Bailie, George R ^a   Evans, Anne ^b   Eisele, George ^b   Venezia, Richard A ^b  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Dosing; Gentamicin; Intraperitoneal; Peritonitis; Pharmacokinetics; Residual renal function; Treatment

Indexed keywords

GENTAMICIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG URINE LEVEL; EQUILIBRIUM DIALYSIS; FEMALE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; PERITONITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0029835080     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601600411     Document Type: Article

References (20)

1. Rubin J, Rogers WA, Tayloe ED, et al. Continuous ambulatory peritoneal dialysis. Ann Intern Med 1980; 92:7-13.
2. Bailie GR, Rasmussen R, Eisele G, et al. Peritonitis rates in CAPD patients using UVXD and O-set systems. Ren Fail 1993; 15:225-30.
3. Moncrief JW, Popovich RP, Nolph KD. The history and current status of continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1990; 16:579-84.
4. Buoncristiani U. Continuous ambulatory peritoneal connection systems. Perit Dial Int 1993; 13(Suppl 2):S139-45.
5. Keane WF, Everette ED, Golper TA, et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1993 update. Perit Dial Int 1993; 13:14-28.
6. Vas SI. Single daily dose of aminoglycosides in the treatment of CAPD peritonitis. Perit Dial Int 1993; 13(Suppl 2):S355-6.
7. Haqqie SS, Bailie GR, Eisele G. Intraperitoneal once-daily gentamicin and once-weekly vancomycin in the treatment of CAPD peritonitis (Abstract). Pharmacotherapy 1994; 14:365.
8. Were AJ, Marsden A, Tooth A, et al. Netilmicin and vancomycin in the treatment of peritonitis in CAPD patients. Clin Nephrol 1992; 37:209-13.
9. Milikin SP, Matzke GR, Keane WF. Antimicrobial treatment of peritonitis associated with CAPD. Perit Dial Int 1991; 11:252-60.
10. Lye WC, Wong PL, van der Straaten JC,et al. A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis (Abstract). Perit Dial Int 1995; 15(Suppl 1):S30.
11. Chadwick D, Turner K, Hair M, et al. Outcome of peritonitis treated with intraperitoneal weekly vancomycin and daily netilmicin.Perit Dial Int 1995; 15(Suppl 1):S24.
12. Paepe MD, Lameire N, Belpaire F, et al. Peritoneal pharmacokinetics of gentamicin in man. Clin Nephrol 1983; 19(3):107-9.
13. Gendeh BS, Saig H, Gibb AG, et al. Gentamicin ototoxicity in continuous ambulatory peritoneal dialysis. J Laryngol Otol 1993; 107(8):681-5.
14. Chong TK, Piraino B, Bernardini J. Vestibular toxicity due to gentamicin in peritoneal dialysis patients. Perit Dial Int 1991; 11(2):152-5.
15. Pancorbo S, Comty C. Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother 1981; 19:605-7.
16. Bailie GR, Haqqie SS, Eisele G, et al. Effectiveness of once-weekly vancomycin and once-daily gentamicin, intraperitoneally, for CAPD peritonitis. Perit Dial Int 1995; 15:269-71.
17. Traynor AM, Nafziger AN, Bertino Jr JS. Aminoglycoside dosing weight correction factors for patients of various body sizes. Antimicrob Agents Chemother 1995; 39(2):545-8.
18. Neal D, Bailie GR. Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis. Clin Pharmacokinet 1990; 18:485-90.
19. Glew RH, Pavuk RA. Stability of vancomycin and aminoglycoside antibiotics in peritoneal dialysis concentrate. Nephron 1982; 30:341-4.
20. Bailie GR, Eisele G, Venezia R,et al. Prediction of serum vancomycin concentration following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis. Clin Pharmacokinet 1992; 22(4):298-307.